Literature DB >> 31259652

Implementation of a Neurogenic Bowel Program for Spinal Cord Injury in the Acute Care Setting: Perceptions of Patients and Staff.

Sarah Borsh1,2, Seema Sikka1,2, Librada Callender1,2, Monica Bennett2, Megan Reynolds1,2, Simon Driver1,2.   

Abstract

A prospect cohort and case-control was employed to (1) establish a neurogenic bowel (NB) program after spinal cord injury (SCI) in the acute care setting; (2) examine clinician knowledge ability to deliver the NB program; and (3) evaluate patient knowledge, satisfaction, and quality of life. Educational in-service describing NB clinical practice guidelines (CPGs) and order set was delivered to staff followed by a pre-/post-education, 3- and 12-month survey. The patient intervention followed 24 patients with NB to evaluate the program and compared to 28 retrospective case-control patients followed by a pre-/post-intervention survey to measure knowledge of SCI, NB program and quality of life. Injury information and bowel medication use was compared between cases and controls. Clinician knowledge of NB CPGs improved. There were no significant clinical differences between patient groups. Patient knowledge and satisfaction improved post-intervention. Education to staff and patients is imperative to facilitate a NB program to meet the needs for individuals with SCI.

Entities:  

Keywords:  Clinical Practice Guidelines; Spinal cord injury; neurogenic bowel; neurogenic bowel program

Mesh:

Year:  2019        PMID: 31259652     DOI: 10.1080/07380577.2019.1633586

Source DB:  PubMed          Journal:  Occup Ther Health Care        ISSN: 0738-0577


  1 in total

1.  Neurogenic Bowel Dysfunction Changes after Osteopathic Care in Individuals with Spinal Cord Injuries: A Preliminary Randomized Controlled Trial.

Authors:  Federica Tamburella; Alessandro Antonio Princi; Jacopo Piermaria; Matteo Lorusso; Giorgio Scivoletto; Marcella Masciullo; Giovanni Cardilli; Paola Argentieri; Marco Tramontano
Journal:  Healthcare (Basel)       Date:  2022-01-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.